Difference between revisions of "Team:NAU-CHINA"

 
(62 intermediate revisions by the same user not shown)
Line 56: Line 56:
  
 
#abstract{
 
#abstract{
−
background-color: rgba(105,115,235,0.9);
+
background-color: rgba(147,251,152,0.9);
 
position: fixed;
 
position: fixed;
−
margin: 20px 15% 0 15%;
+
margin: 1.25em 20em 0 20em;
 
height: 90%;
 
height: 90%;
 
                         z-index:-1;
 
                         z-index:-1;
 
                         font-family:'Comic Sans MS','Arial Black';
 
                         font-family:'Comic Sans MS','Arial Black';
 
display: none;
 
display: none;
 +
                        border:solid 1px white;
 +
 
}
 
}
 
#scroll_to_bottom{
 
#scroll_to_bottom{
−
margin: 30% 45%;
 
 
position: fixed;
 
position: fixed;
 
text-align: center;
 
text-align: center;
 
color: #ffffff;
 
color: #ffffff;
 
font-weight: bold;
 
font-weight: bold;
−
                        font-size:12px;
+
bottom: 10%;
 +
left: 40%;
 
}
 
}
  
−
@media screen and (max-width: 1220px) {
+
@media screen and (max-width: 1170px) {
  
 
    .menu{
 
    .menu{
 
        display: none;
 
        display: none;
−
        opacity: 0;
 
 
    }
 
    }
  
Line 85: Line 86:
  
 
}
 
}
 +
@media screen and (max-width: 980px){
 +
#ClickBack{
 +
display: none;
 +
}
 +
#abstract{
 +
background-color: rgba(147,251,152,0.9);
 +
position: fixed;
 +
margin: 45% auto 0 auto;
 +
min-height: 40em;
 +
            height:auto;
 +
            z-index:-1;
 +
            font-family:'Comic Sans MS','Arial Black';
 +
            border:solid 1px white;
 +
            display: block;
 +
            overflow:hidden;
 +
}
 +
#scroll_to_bottom{
 +
display: none;
 +
}
 +
body{
 +
background-color: white;
 +
}
 +
    .menu{
 +
        display: none;
 +
    }
  
−
@media screen and (min-width: 1220px) {
+
    .container {
 +
        display: block;
 +
    }
 +
}
 +
@media screen and (min-width: 1170px) {
  
 
    .menu{
 
    .menu{
Line 98: Line 128:
 
}
 
}
  
−
                 #guanjian {margin-left:20%;font-family:'Comic Sans MS','Arial Black';}
+
                 #abstract #guanjian {margin-left:7em;font-family:'Comic Sans MS','Arial Black';font-size:16px;}
−
h1,p{
+
p{
−
margin-left: 20%;
+
margin-left: 5em;
−
margin-right: 20%;
+
margin-right: 5em;
−
margin-top: 40px;
+
                        font-family:'Comic Sans MS','Arial Black';
 +
}
 +
h1{
 +
margin-left: 4.5em;
 +
margin-right: 5em;
 +
margin-top: 3.5em;
 
                         font-family:'Comic Sans MS','Arial Black';
 
                         font-family:'Comic Sans MS','Arial Black';
 
}
 
}
−
 
 
#ClickBack{
 
#ClickBack{
 
text-align: center;
 
text-align: center;
 
position: fixed;
 
position: fixed;
−
bottom: 3%;
+
bottom: 3em;
−
right: 15%;
+
right: 18em;
 
                         display:none;
 
                         display:none;
−
                         font-family:ZiTi,'Comic Sans MS','Arial Black';
+
                         font-family:'Comic Sans MS','Arial Black';
 
}
 
}
  
 
#ClickBack img{
 
#ClickBack img{
−
width: 100px;
+
width: 6em;
 
}
 
}
 +
 
</style>
 
</style>
  
Line 139: Line 174:
 
   $("#abstract").slideToggle();
 
   $("#abstract").slideToggle();
 
   $("#ClickBack").slideToggle();
 
   $("#ClickBack").slideToggle();
 +
  $("#scroll_to_bottom").slideToggle();
 
   });
 
   });
  
Line 144: Line 180:
 
     $("#abstract").fadeOut("slow");
 
     $("#abstract").fadeOut("slow");
 
     $("#ClickBack").fadeOut("slow");
 
     $("#ClickBack").fadeOut("slow");
 +
    $("#scroll_to_bottom").fadeIn("slow");
 
   });
 
   });
 
});
 
});
 +
 
</script>
 
</script>
  
 
</head>
 
</head>
 
 
−
<body >
+
<body>
  
−
<!-- small screen menu -->
+
<!-- small screen menu -->
 
 
 
<div class="container" >
 
<div class="container" >
Line 174: Line 212:
 
<a href="https://2016.igem.org/Team:NAU-CHINA/Part_Collection"> PARTS</a>
 
<a href="https://2016.igem.org/Team:NAU-CHINA/Part_Collection"> PARTS</a>
 
</li>
 
</li>
 +
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Safety"> SAFETY</a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Safety"> SAFETY</a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Attributions"> ATTRIBUTION</a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Attributions"> ATTRIBUTION</a></li>
Line 209: Line 248:
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Demonstrate">Demonstrate </a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Demonstrate">Demonstrate </a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Model">Model </a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Model">Model </a></li>
−
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Result">Result </a></li>
 
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Notebook">Notebook </a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Notebook">Notebook </a></li>
 
</ul>
 
</ul>
Line 215: Line 253:
 
<li><a>PARTS</a>
 
<li><a>PARTS</a>
 
<ul class="submenu">
 
<ul class="submenu">
 +
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Part_List">Part List</a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Basic_Part">Basic Part</a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Basic_Part">Basic Part</a></li>
−
<li><a href="http://https://2016.igem.org/Team:NAU-CHINA/Composite_Part">Composite Part</a></li>
+
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Composite_Part">Composite Part</a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Part_Collection">Collection</a></li>
 
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Part_Collection">Collection</a></li>
−
 
 
</ul>
 
</ul>
 
</li>
 
</li>
Line 235: Line 273:
 
</nav>
 
</nav>
 
<img src="https://static.igem.org/mediawiki/2016/e/e8/NAU_CHINA_2016WIKI_HOME.jpeg"  onload="ChangeImg(this)" style="z-index:-60;position:absolute;left:0;top:0px"><!--backgroundimg-->
 
<img src="https://static.igem.org/mediawiki/2016/e/e8/NAU_CHINA_2016WIKI_HOME.jpeg"  onload="ChangeImg(this)" style="z-index:-60;position:absolute;left:0;top:0px"><!--backgroundimg-->
−
+
<div>
 
<div name="abstract" id="abstract">
 
<div name="abstract" id="abstract">
−
<h1>The Birth of Healer & A Story of Us</h1>
+
<br><br>
−
<p>Several ideas were created and several ideas were denied. Our eyes were blocked by <b style="font-weight: bold;color: white;">3-phenoxybenzoate acid(3-PBA)</b>, the main intermediate product of pyrethroids. But what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly and how to degrade it through employing microbial biodegradation techniques? Once our Healer (the engineered bacteria) were born, how to put it into practice? From knowing to deep knowing, our efforts made it real.</p><br>
+
<h1 style="font-family:'Comic Sans MS','Arial Black';font-size:20px;">The Birth of Healer & A Story of Us</h1>
 +
<p style="font-family:'Comic Sans MS','Arial Black';font-size:17px;">Several ideas were created and several ideas were denied. Our eyes were blocked by <b style="font-weight: bold;color:blue;">3-phenoxybenzoate acid(3-PBA)</b>, the main intermediate product of pyrethroids. But what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly and how to degrade it through employing microbial biodegradation techniques? Once our Healer (the engineered bacteria) were born, how to put it into practice? From knowing to deep knowing, our efforts made it real.</p><br>
 
<ul id="guanjian">Key words:
 
<ul id="guanjian">Key words:
 
<li>Cause <span>(what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly?)</span></li>
 
<li>Cause <span>(what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly?)</span></li>
Line 244: Line 283:
 
<li>Extention <span>(How to put it into practice?)</span></li>
 
<li>Extention <span>(How to put it into practice?)</span></li>
 
</ul>
 
</ul>
−
 
+
<br><br>
 
</div>
 
</div>
 +
<br style="clear:both;"></div>
 
<div  id="ClickBack">
 
<div  id="ClickBack">
 
<img src="https://static.igem.org/mediawiki/2016/e/e9/NAU_CHINA_2016_ClickToBack.gif">
 
<img src="https://static.igem.org/mediawiki/2016/e/e9/NAU_CHINA_2016_ClickToBack.gif">

Latest revision as of 18:17, 19 October 2016



The Birth of Healer & A Story of Us

Several ideas were created and several ideas were denied. Our eyes were blocked by 3-phenoxybenzoate acid(3-PBA), the main intermediate product of pyrethroids. But what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly and how to degrade it through employing microbial biodegradation techniques? Once our Healer (the engineered bacteria) were born, how to put it into practice? From knowing to deep knowing, our efforts made it real.


    Key words:
  • Cause (what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly?)
  • Method (How to degrade it through employing microbial biodegradation techniques?)
  • Extention (How to put it into practice?)



Click Me Back

Click here to see more